Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday?
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance